Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  LMB-2 immunotoxin
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
LMB-2 Immunotoxin in Treating Patients with Hairy Cell Leukemia
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 06-C-0150, NCI-2009-00231, CDR0000482415, NCT00337311, P6760, 7834, NCI-06-C-0150, NCI-P6760, NCI-7834, NCT00321555
LMB-2 Immunotoxin, Fludarabine Phosphate, and Cyclophosphamide in Treating Patients with T-cell Leukemia
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 09C0025, NCI-2009-00296, 09-25-0099, 8226/NCI 09C0025, CDR0000648219, NCI 09C0025, NCT00794833, 8226, NCT00924170
Start Over